Joel Greenblatt Repligen Corp Transaction History

Gotham Asset Management, LLC

$9.41 Billion
Q3 2024

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Repligen Corp stock. As of the latest transaction made, Gotham Asset Management, LLC holds 31,241 shares of RGEN stock, worth $4.55 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

31,241

Previous 17,740 76.1%

Holding current value

$4.55 Million

Previous $2.24 Million 107.92%

% of portfolio

0.05%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$119.79 - $167.35 $1.62 Million - $2.26 Million	13,501 Added 76.1%	31,241 $4.65 Million
Q2 2024 Aug 14, 2024	BUY	$120.0 - $182.95 $1.55 Million - $2.37 Million	12,955 Added 270.74%	17,740 $2.24 Million
Q1 2024 May 15, 2024	BUY	$170.78 - $208.42 $5,635 - $6,877	33 Added 0.69%	4,785 $880,000
Q4 2023 Feb 14, 2024	BUY	$114.17 - $185.35 $19,865 - $32,250	174 Added 3.8%	4,752 $854,000
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $1.66 Million - $2.11 Million	-11,976 Reduced 72.35%	4,578 $727,000
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $1.59 Million - $2.07 Million	11,463 Added 225.16%	16,554 $2.34 Million
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $324,100 - $416,208	-2,101 Reduced 29.21%	5,091 $857,000
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $111,582 - $151,524	-687 Reduced 8.72%	7,192 $1.22 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $490,243 - $782,977	-3,056 Reduced 27.95%	7,879 $1.47 Million
Q2 2022 Aug 15, 2022	BUY	$140.68 - $188.02 $428,933 - $573,272	3,049 Added 38.66%	10,935 $1.78 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $257,581 - $412,220	1,598 Added 25.41%	7,886 $1.48 Million
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $80,961 - $99,561	327 Added 5.49%	6,288 $1.67 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $149,778 - $249,317	-769 Reduced 11.43%	5,961 $1.72 Million
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $82,609 - $103,627	-458 Reduced 6.37%	6,730 $1.31 Million
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $254,401 - $354,887	-1,718 Reduced 19.29%	7,188 $1.38 Million
Q3 2020 Nov 16, 2020	SELL	$122.51 - $158.27 $111,851 - $144,500	-913 Reduced 9.3%	8,906 $1.31 Million
Q2 2020 Aug 13, 2020	SELL	$94.33 - $140.48 $84,425 - $125,729	-895 Reduced 8.35%	9,819 $1.21 Million
Q1 2020 May 15, 2020	SELL	$84.96 - $109.14 $108,833 - $139,808	-1,281 Reduced 10.68%	10,714 $1.03 Million
Q4 2019 Feb 14, 2020	SELL	$73.84 - $93.08 $2.05 Million - $2.58 Million	-27,703 Reduced 69.78%	11,995 $1.11 Million
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $1.82 Million - $2.26 Million	23,682 Added 147.86%	39,698 $3.04 Million
Q2 2019 Aug 14, 2019	SELL	$54.2 - $85.95 $353,709 - $560,909	-6,526 Reduced 28.95%	16,016 $1.38 Million
Q1 2019 May 15, 2019	SELL	$49.45 - $62.8 $487,181 - $618,705	-9,852 Reduced 30.41%	22,542 $1.33 Million
Q4 2018 Feb 14, 2019	BUY	$48.26 - $68.88 $752,228 - $1.07 Million	15,587 Added 92.74%	32,394 $1.71 Million
Q3 2018 Nov 14, 2018	BUY	$46.8 - $58.97 $172,972 - $217,953	3,696 Added 28.19%	16,807 $932,000
Q2 2018 Aug 14, 2018	BUY	$35.26 - $47.04 $54,758 - $73,053	1,553 Added 13.44%	13,111 $617,000
Q1 2018 May 15, 2018	SELL	$30.92 - $37.27 $399,393 - $481,416	-12,917 Reduced 52.78%	11,558 $418,000
Q4 2017 Feb 14, 2018	SELL	$32.53 - $38.92 $3.07 Million - $3.67 Million	-94,413 Reduced 79.41%	24,475 $888,000
Q3 2017 Nov 14, 2017	BUY	$36.98 - $46.06 $4.4 Million - $5.48 Million	118,888	118,888 $4.56 Million

Others Institutions Holding RGEN

# of Institutions

476

Shares Held

55.6M

Call Options Held

311K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.09B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account